World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
44
Citations
7971
World Ranking
5128
National Ranking
351

Best Publications

  • Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.

    Philipp Koehler;Matteo Bassetti;Arunaloke Chakrabarti;Sharon C.A. Chen;Sharon C.A. Chen

  • COVID-19 associated pulmonary aspergillosis.

    Philipp Koehler;Oliver A. Cornely;Bernd W. Böttiger;Fabian Dusse

  • COVID-19 associated pulmonary aspergillosis (CAPA)—from immunology to treatment

    Amir Arastehfar;Agostinho Carvalho;Frank L. van de Veerdonk;Jeffrey D. Jenks

  • Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology

    Martin Hoenigl;Jon Salmanton-García;Thomas J. Walsh;Thomas J. Walsh;Marcio Nucci

  • Low-Avidity CD4 + T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19.

    Petra Bacher;Elisa Rosati;Daniela Esser;Gabriela Rios Martini

  • COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).

    Livio Pagano;Livio Pagano;Jon Salmanton-García;Francesco Marchesi;Alessandro Busca

  • Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis.

    Philipp Koehler;Melanie Stecher;Oliver A Cornely;Daniela Koehler

  • COVID-19-Associated Pulmonary Aspergillosis, March-August 2020.

    Jon Salmanton-García;Rosanne Sprute;Jannik Stemler;Michele Bartoletti

  • Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology.

    Juergen Prattes;Joost Wauters;Daniele Roberto Giacobbe;Jon Salmanton-García

  • Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM

    Unknown

  • Diagnosing COVID-19-associated pulmonary aspergillosis.

    Paul E. Verweij;Jean Pierre Gangneux;Matteo Bassetti;Roger J.M. Brüggemann

  • Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

    Unknown

  • Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.

    Paul E. Verweij;Paul E. Verweij;Roger J.M. Brüggemann;Elie Azoulay;Matteo Bassetti

  • Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM.

    Unknown

  • Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19.

    Sebastian J Theobald;Alexander Simonis;Theodoros Georgomanolis;Christoph Kreer

  • Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study.

    Unknown

  • Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

    Unknown

  • Rare mould infections caused by Mucorales, Lomentospora prolificans and Fusarium, in San Diego, CA: the role of antifungal combination therapy.

    Jeffrey D. Jenks;Sharon L. Reed;Danila Seidel;Philipp Koehler

  • European candidaemia is characterised by notable differential epidemiology and susceptibility pattern; Results from the ECMM Candida III study.

    Unknown

  • Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study.

    Philipp Koehler;Axel Hamprecht;Oliver Bader;Isabelle Bekeredjian-Ding

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: